417 related articles for article (PubMed ID: 12112963)
1. Recombinant gonadotropins.
Lathi RB; Milki AA
Curr Womens Health Rep; 2001 Oct; 1(2):157-63. PubMed ID: 12112963
[TBL] [Abstract][Full Text] [Related]
2. [Clinical use of recombinant gonadotropins (FSH, LH, hCG)].
Antoine JM; Loumaye E; Alvarez S; Merviel P; Cornet D; Mandelbaum J; Salat-Baroux J
Contracept Fertil Sex; 1997 Feb; 25(2):141-6. PubMed ID: 9116774
[TBL] [Abstract][Full Text] [Related]
3. Oestradiol and immunoreactive inhibin-like secretory patterns following controlled ovarian hyperstimulation with urinary (Metrodin) or recombinant follicle stimulating hormone (Puregon).
Mitchell R; Buckler HM; Matson P; Lieberman B; Burger HG; Hilton B; Horne G; Dyson M; Robertson WR
Hum Reprod; 1996 May; 11(5):962-7. PubMed ID: 8671371
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of recombinant human follicle-stimulating hormone in improving oocyte quality in assisted reproductive techniques.
Cheon KW; Byun HK; Yang KM; Song IO; Choi KH; Yoo KJ
J Reprod Med; 2004 Sep; 49(9):733-8. PubMed ID: 15493565
[TBL] [Abstract][Full Text] [Related]
5. Comparison of recombinant human luteinising hormone (r-hLH) and human menopausal gonadotropin (hMG) in assisted reproductive technology.
Baer G; Loumaye E
Curr Med Res Opin; 2003; 19(2):83-8. PubMed ID: 12740151
[TBL] [Abstract][Full Text] [Related]
6. Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization-embryo transfer.
Doldi N; Persico P; Di Sebastiano F; Marsiglio E; Ferrari A
Gynecol Endocrinol; 2006 May; 22(5):235-8. PubMed ID: 16785142
[TBL] [Abstract][Full Text] [Related]
7. Results of controlled ovarian stimulation for ART in poor responders according to the short protocol using different gonadotrophins combinations.
Loutradis D; Elsheikh A; Kallianidis K; Drakakis P; Stefanidis K; Milingos S; Michalas S
Arch Gynecol Obstet; 2004 Dec; 270(4):223-6. PubMed ID: 13680266
[TBL] [Abstract][Full Text] [Related]
8. Clinical effects of ovulation induction with recombinant follicle-stimulating hormone supplemented with recombinant luteinizing hormone or low-dose recombinant human chorionic gonadotropin in the midfollicular phase in microdose cycles in poor responders.
Berkkanoglu M; Isikoglu M; Aydin D; Ozgur K
Fertil Steril; 2007 Sep; 88(3):665-9. PubMed ID: 17292895
[TBL] [Abstract][Full Text] [Related]
9. Effects of recombinant LH (rLH) supplementation during controlled ovarian hyperstimulation (COH) in normogonadotrophic women with an initial inadequate response to recombinant FSH (rFSH) after pituitary downregulation.
De Placido G; Alviggi C; Mollo A; Strina I; Ranieri A; Alviggi E; Wilding M; Varricchio MT; Borrelli AL; Conforti S
Clin Endocrinol (Oxf); 2004 May; 60(5):637-43. PubMed ID: 15104569
[TBL] [Abstract][Full Text] [Related]
10. Gonadotropins in the treatment of infertility.
Butt WR
Acta Endocrinol Suppl (Copenh); 1988; 288():51-7. PubMed ID: 3138866
[TBL] [Abstract][Full Text] [Related]
11. The effectiveness and safety of recombinant human LH to support follicular development induced by recombinant human FSH in WHO group I anovulation: evidence from a multicentre study in Spain.
Burgués S;
Hum Reprod; 2001 Dec; 16(12):2525-32. PubMed ID: 11726569
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized controlled trial.
De Placido G; Alviggi C; Perino A; Strina I; Lisi F; Fasolino A; De Palo R; Ranieri A; Colacurci N; Mollo A;
Hum Reprod; 2005 Feb; 20(2):390-6. PubMed ID: 15576390
[TBL] [Abstract][Full Text] [Related]
13. [Recent progress in the hormonal treatment of sterility].
Fanard A
Brux Med; 1975 Jul; 55(7):401-14. PubMed ID: 1098749
[TBL] [Abstract][Full Text] [Related]
14. Homologous intrauterine insemination in controlled ovarian hyperstimulation cycles: a comparison among three different regimens.
Casadei L; Zamaro V; Calcagni M; Ticconi C; Dorrucci M; Piccione E
Eur J Obstet Gynecol Reprod Biol; 2006 Dec; 129(2):155-61. PubMed ID: 16687201
[TBL] [Abstract][Full Text] [Related]
15. Ovulation induction: a mini review.
Messinis IE
Hum Reprod; 2005 Oct; 20(10):2688-97. PubMed ID: 16006478
[TBL] [Abstract][Full Text] [Related]
16. IVF/ICSI outcome and serum LH concentration on day 1 of ovarian stimulation with recombinant FSH under pituitary suppression.
Bjercke S; Fedorcsak P; Abyholm T; Storeng R; Ertzeid G; Oldereid N; Omland A; Tanbo T
Hum Reprod; 2005 Sep; 20(9):2441-7. PubMed ID: 15919773
[TBL] [Abstract][Full Text] [Related]
17. Recombinant FSH vs. urinary FSH for ovarian stimulation in in vitro fertilization.
Meden-Vrtovec H; Mocnik-Roznik S; Tomazevic T; Virant-Klun I
J Reprod Med; 2003 Oct; 48(10):799-803. PubMed ID: 14619648
[TBL] [Abstract][Full Text] [Related]
18. Differences in gene expression of granulosa cells from women undergoing controlled ovarian hyperstimulation with either recombinant follicle-stimulating hormone or highly purified human menopausal gonadotropin.
Grøndahl ML; Borup R; Lee YB; Myrhøj V; Meinertz H; Sørensen S
Fertil Steril; 2009 May; 91(5):1820-30. PubMed ID: 18439596
[TBL] [Abstract][Full Text] [Related]
19. Ovulation induction.
Marshall JR
Obstet Gynecol; 1970 Jun; 35(6):963-70. PubMed ID: 4911159
[No Abstract] [Full Text] [Related]
20. A randomized single-blind controlled trial of letrozole as a low-cost IVF protocol in women with poor ovarian response: a preliminary report.
Goswami SK; Das T; Chattopadhyay R; Sawhney V; Kumar J; Chaudhury K; Chakravarty BN; Kabir SN
Hum Reprod; 2004 Sep; 19(9):2031-5. PubMed ID: 15217999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]